NUREXONE BIOLOGIC INC.

Research NUREXONE BIOLOGIC INC. (J90) on Bullrun: market cap EUR 31.28M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerJ90
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 31.28M
• Financial periodQ4 2025
• Net income-EUR 1.40M
• Free cash flow-EUR 1.18M

Valuation Snapshot

latest market cap is EUR 31.28M.

About NUREXONE BIOLOGIC INC.

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.

Frequently asked questions

What is NUREXONE BIOLOGIC INC.'s market cap?

NUREXONE BIOLOGIC INC.'s market capitalization is EUR 31.28M.

What does NUREXONE BIOLOGIC INC. do?

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries.